EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Burden of Disease Due to Respiratory Syncytial Virus in Adults in Five Middle-Income Countries

Jorge A Gómez iD, Otavio Cintra iD, Arnas Berzanskis iD, Salma Pacheco, Henny Jaswantlal, Abdelkader El Hasnaoui, Desirée A M van Oorschot iD, Adriana Guzman-Holst

Infectious Disease Reports · 15.08.2024 · 16 (4) · 750-762

DOI: 10.3390/idr16040057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infectious Disease Reports, online erschienen am 15.08.2024. Verfasst von Jorge A Gómez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Value Evidence & Outcomes, Vaccines, Emerging Markets, GSK, Buenos Aires 1429, Argentina. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GlaxoSmithKline Biologicals SA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory syncytial virus (RSV) is an important cause of severe respiratory disease in older adults. Understanding the disease burden is crucial for guiding vaccination policy and raising disease awareness. We estimated the burden of RSV hospitalizations and deaths in adults in five middle-income countries: Argentina, Brazil, Chile, Mexico, and Malaysia. Hospital discharge and death statistics due to any respiratory disease (ICD-10 codes: J00–99) from 2010 to 2022 were obtained. The RSV attributable burden on hospitalizations and deaths by age group was determined for 2019 using previously published estimates. Latin American countries showed distinct annual peaks in respiratory-related hospitalizations and deaths during winter months that were absent in Malaysia. Among ≥20-year-olds in 2019, there were 14,604 RSV-attributable hospitalizations nationally in Argentina, 44,323 in Brazil, 4529 in Chile, 7416 in Malaysia, and 8651 in Mexico, and 60–74% in ≥65-year-olds. There were also 3518 RSV-attributable deaths in Argentina, 9115 in Brazil, 801 in Chile, 704 in Malaysia, and 3806 in Mexico 79–88% in ≥65-year-olds. Incidences of RSV-attributable hospitalizations in ≥75-year-olds ranged between 256.3 and 294.3 per 100,000 population, and deaths between 33.6 and 112.9 per 100,000 population. RSV is associated with a substantial disease burden beyond pediatric age groups, and preventive vaccines could have a major impact on this burden, especially in older adults.

Schlagwörter

Stichwörter der Autor:innen

Latin AmericaMalaysiaadultcase fatalityhospitalizationmortalityrespiratory syncytial virus

Autor:innen und Institutionen

  • Value Evidence & Outcomes, Vaccines, Emerging Markets, GSK, Buenos Aires 1429, Argentina.
  • Medical Affairs, Vaccines, Emerging Markets, GSK, Sao Paulo 04001-083, Brazil.
  • Medical Affairs, Vaccines, Emerging Markets, GSK, London WC1A 1DG, UK.
  • Medical Affairs, Vaccines, Emerging Markets, GSK, Mexico City 03330, Mexico.
  • Medical Affairs, Vaccines, Emerging Markets, GSK, Petaling Jaya 47800, Selangor, Malaysia.
  • Medical Affairs, Vaccines, Emerging Markets, GSK, Dubai 50199, United Arab Emirates.

ORCID-Profile: Jorge A Gómez, Otavio Cintra, Arnas Berzanskis, Desirée A M van Oorschot

Förderung

  • GlaxoSmithKline Biologicals SA

Zitieren

APA

Gómez, J. A., Cintra, O., Berzanskis, A., Pacheco, S., Jaswantlal, H., Hasnaoui, A. E., van Oorschot, D. A. M., & Guzman-Holst, A. (2024). Burden of Disease Due to Respiratory Syncytial Virus in Adults in Five Middle-Income Countries. Infectious Disease Reports, 16(4), 750-762. https://doi.org/10.3390/idr16040057

Vancouver

Gómez JA, Cintra O, Berzanskis A, Pacheco S, Jaswantlal H, Hasnaoui AE, et al. Burden of Disease Due to Respiratory Syncytial Virus in Adults in Five Middle-Income Countries. Infectious Disease Reports. 2024;16(4):750-762. doi:10.3390/idr16040057

BibTeX
@article{Gmez2024,
  author = {Gómez, Jorge A and Cintra, Otavio and Berzanskis, Arnas and Pacheco, Salma and Jaswantlal, Henny and Hasnaoui, Abdelkader El and van Oorschot, Desirée A M and Guzman-Holst, Adriana},
  title = {Burden of Disease Due to Respiratory Syncytial Virus in Adults in Five Middle-Income Countries},
  journal = {Infectious Disease Reports},
  year = {2024},
  volume = {16},
  number = {4},
  pages = {750--762},
  doi = {10.3390/idr16040057}
}
Kostenlos starten →